Supplements that quickly raise blood ketones without fasting or a low-carb diet, sold as potent but costly esters or gentler but weaker salts. The most certain effects are raising blood ketones and modestly lowering blood sugar, clearest when blood sugar is already high. Heart, appetite, and brain-fuel signals are early; the longevity case rests on signaling biology and animal data. (Full Review)

Protocol

Form & Dose

Ketone monoester, 0.3–0.5 g/kg

Commonly 10–25 g; raises blood BHB to ~2–6 mM. Salts and 1,3-butanediol are weaker alternatives.

Timing

Goal-dependent

Fasted or before a low-carb meal for largest glucose/ketosis effect; before demanding tasks for brain or muscle fuel. Large doses near bedtime undesirable.

Dosing Cadence

Single vs. split dosing

A single dose suffices for a discrete acute effect; sustained ketosis requires repeated split dosing, which also reduces per-dose GI burden.

Time to effect

Blood ketone rise

15–30 minutes

Blood ketones rise within 15–30 minutes of a dose.

Metabolic effects

Same window, fade over 3–4 h

Glucose lowering and appetite suppression appear within the same window and fade over 3–4 hours.

Duration of ketosis

~3–4 hours per dose

BHB half-life is ~1–2 h; a monoester dose produces ketosis lasting about 3–4 h. No loading period.

Benefits

High: Acute elevation of blood ketones; acute lowering of blood glucose

Medium: Improved cardiac function in heart failure; appetite suppression and support for weight management

Low: Cognitive and brain-energy support; anti-inflammatory signaling

Speculative: Longevity and healthspan extension; neuroprotection and resilience to brain injury

Contraindications

Type 1 diabetes or any history of ketoacidosis

Advanced kidney disease (eGFR <30 mL/min/1.73 m²)

Advanced liver disease (Child-Pugh Class C)

Pregnancy or breastfeeding

Children

Key Interactions

Glucose-lowering medications (insulin, sulfonylureas such as glipizide, SGLT2 inhibitors such as empagliflozin)

Antihypertensive drugs and other sodium-sensitive regimens (with ketone salts)

Over-the-counter antacids and alkalinizing agents

Supplements with additive glucose-lowering or appetite effects (berberine, alpha-lipoic acid, chromium)

Caffeine and MCT oil

Alcohol

Risk & Side Effects

High: Gastrointestinal distress; unpalatable taste

Medium: Increased resting heart rate; electrolyte and mineral load from ketone salts

Low: Hypoglycemia risk in combination with glucose-lowering therapy; suppression of endogenous fat oxidation

Speculative: Unknown long-term metabolic consequences; acid-base and renal considerations with very high intake

Monitoring

Marker	Target	Why
Blood β-hydroxybutyrate (BHB)	1–3 mM after dosing	Confirms the supplement actually raised ketones to an effective level
Fasting glucose	70–90 mg/dL (3.9–5.0 mM)	Tracks the metabolic effect most consistently produced by ketones
HbA1c	<5.4%	Captures whether any glucose benefit translates over time
Resting heart rate	50–70 bpm	Detects the dose-dependent heart-rate increase associated with ketones
Basic metabolic panel (electrolytes, eGFR)	Sodium 135–142 mEq/L; eGFR >90 mL/min/1.73 m²	Screens for mineral overload from salts and protects borderline kidney function
Lipid panel (triglycerides, LDL, HDL)	Triglycerides <80 mg/dL	Monitors for any metabolic shifts with sustained use

Cadence: Baseline panel, a check at 4–8 weeks if using regularly, then every 6–12 months.

Qualitative Assessment

Energy stability and absence of an afternoon crash after dosing
Subjective appetite and hunger control in the hours after a dose
Cognitive clarity or focus during demanding tasks
Gastrointestinal comfort versus distress at a given dose
Exercise perceived exertion and recovery quality

Exogenous Ketones for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment